Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma

Published:2018-11 Issue:11 Volume:29 Page:1502-1510.e1
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Gabr Ahmed^ORCID,Abouchaleh Nadine,Ali Rehan,Baker Talia,Caicedo Juan,Katariya Nitin,Abecassis Michael,Riaz Ahsun,Lewandowski Robert J.,Salem Riad^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population;Schwarz;Am J Surg,2008

2. Portal vein embolization before right hepatectomy: prospective clinical trial;Farges;Ann Surg,2003

3. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group;Torzilli;Ann Surg,2013

4. (90)Y radiation lobectomy: outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes;Lewandowski;J Surg Oncol,2016

5. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma;Salem;Gastroenterology,2016

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors;Journal of Vascular and Interventional Radiology;2024-07

3. Image-guided percutaneous strategies to improve the resectability of HCC: Portal vein embolization, liver venous deprivation, or radiation lobectomy?;Clinical Imaging;2024-07

4. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma;Biomedicines;2024-06-27

5. Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review;Frontiers in Immunology;2024-02-19